A multicenter international observational study of the long-term safety of Infliximab (REMICADE)
DEC-NET Serial number IT463
Published online09/09/2005 14.42.00
Last updated09/09/2005 14.52.28
Other protocol ID number
Current trial status
Major Disease
(ICD9 class)		UNSPECIFIED ADVERSE EFFECT OF DRUG MEDICINAL AND B
Experimental drug
INFLIXIMAB
GenderBoth
Age (range)

Eligibility criteria

Trial design/methodology
Phase
Kind of studySafety
Design
Principal investigator
NameProf. Alberto Martini
InstitutionIstituto G. Gaslini
Postal addressLargo G. Gaslini, 5 - 16148
CityGenova
CountryITALY
Phone010 5636386
Fax
E-mailalbertomartini@ospedale-gaslini.ge.it


Promoter
Centocor (Industry)

ISRCTN  EudraCT